PROSTROLANE INNER B SE (2x1ml)
zoom_out_map
chevron_left chevron_right
-25% New

PROSTROLANE INNER B SE (2x1ml)

PROSTROLANE INNER B SE is a transparent sustained-release gel to be injected into the subcutaneous layer. Complex based on concentrated and encapsulated biomimetic peptides whose lipolytic, anti-lipogenesis action allows a reduction in bags under the eyes. Hyaluronic acid (0.7%), PBS (phosphate-buffered saline), Peptide complex.

€130.50 (tax incl.) €174.00 -25% €130.50 (tax excl.)
Tax excluded

Description

PROSTROLANE INNER B SE (2x1ml) CAREGEN

STRICT MEDICAL INJECTABLE USE.

DESCRIPTION

PROSTROLANE INNER B SE is a transparent sustained-release gel to be injected into the subcutaneous layer.PROSTROLANE INNER B SE is a complex based on concentrated and encapsulated biomimetic peptides whose lipolytic, anti-lipogenesis action allows a reduction in bags under the eyes. Innovative new sustained-release injectables and new peptide technology. To reduce bags under the eyes. PROSTROLANE INNER B SE is recommended for smoothing surface irregularities of the skin. PROSTROLANE INNER B SE is specially formulated for the under-eye area. Helps reduce bags under the eyes. Improved formula for specific area. New patented peptide to reduce bags under the eyes. Two-Week Sustained Release Technology.

INDICATION

PROSTROLANE INNER B SE is recommended for smoothing surface irregularities of the skin. Specially formulated for the under-eye area. Helps reduce bags under the eyes.

INJECTION ZONES

Pockets generated by fat cells.

INJECTION VOLUME

0.3~0.4 ml on each side of the area. Volume per point: 0.03 ~ 0.05 cc per point.

INJECTION DEPTH

Subcutaneous layer.

COMPOSITION

Hyaluronic acid (0.7%), PBS (phosphate-buffered saline), Peptide complex (Nonapeptide-32, Pentapeptide-43, Tripeptide-41, Octapeptide-11).

​PROTOCOL

2 sessions 2 weeks apart.

Data sheet

0.12 kg
30049000